in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Lonza on Track with China Expansions
12:26 PM MDT | July 26, 2007 | Alex Scott
Lonza is on track, if not ahead of schedule, with a $200-million investment to increase its fine chemical manufacturing capacity 60% by 2012, Lonza’s CEO Stefan Borgas tells CW. The company recently completed the first phase of construction at its Nansha, China complex, Borgas said last week. “The small-scale plant is already undergoing pilot and test runs,” he says. The second phase of the project involves building a large-scale manufacturing unit at the site scheduled for startup in 2008. The company is also planning to build another...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee